Victrex plc (VCT) Stock Rating Lowered by Peel Hunt
Victrex plc (LON:VCT) was downgraded by analysts at Peel Hunt to a “hold” rating in a report released on Tuesday. They currently have a GBX 2,300 ($30.35) price objective on the stock. Peel Hunt’s target price would suggest a potential downside of 4.09% from the stock’s current price.
Several other equities analysts also recently commented on the company. Liberum Capital reaffirmed a “buy” rating and issued a GBX 2,240 ($29.56) target price on shares of Victrex plc in a research report on Monday, September 4th. Credit Suisse Group reaffirmed an “outperform” rating on shares of Victrex plc in a research report on Friday, July 21st. J P Morgan Chase & Co upped their target price on Victrex plc from GBX 1,800 ($23.75) to GBX 2,150 ($28.37) and gave the company a “neutral” rating in a research report on Tuesday, September 5th. Berenberg Bank raised Victrex plc to a “buy” rating and upped their target price for the company from GBX 2,000 ($26.39) to GBX 2,600 ($34.31) in a research report on Wednesday, September 6th. Finally, UBS AG assumed coverage on Victrex plc in a research report on Monday, August 21st. They issued a “neutral” rating and a GBX 2,050 ($27.05) target price on the stock. Eight research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Victrex plc currently has a consensus rating of “Hold” and a consensus target price of GBX 2,191.64 ($28.92).
About Victrex plc
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Stock Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related stocks with our FREE daily email newsletter.